Senegal: Solidarity With Neighbours - Senegal Offers 20,000 Doses of Vaccine to Gambia, Guinea Bissau

24 February 2021

Senegal has offered 20,000 doses of COVID-19 vaccine to The Gambia and Guinea Bissau as a show of solidarity with its West African neighbors, Senegalese media reported on Monday.

President Macky Sall, who received 200,000 doses of Covid-19 vaccines produced by the Chinese laboratory Sinopharm last Wednesday, decided to show "solidarity" with his "neighbours" in The Gambia and Guinea Bissau.

Speaking at the 20th edition of the International Economic Forum on Africa via videoconference, President Sall said: "We have decided to make 10% of this vaccine available to two neighboring countries, or 20,000 doses for Gambia and Guinea Bissau as an African solidarity. "

"I believe we will continue to do more if we manage to have more doses," Senegalese media outlet lejecos quoted him saying.

The Senegalese government wants to vaccinate all citizens who wish to receive COVID-19 vaccination by 2022, the country's health minister said.

Health and Social Action Minister Abdoulaye Diouf Sarr told daily paper Le Soleil that Senegal would kick off "an emergency phase" of vaccination for frontline health workers, people over 60 years and people with underlying health conditions.

Since confirming its first case in March last year, Senegal has so far registered 33,099 confirmed cases with 27,428 recoveries and 814 deaths.


More From: The Point

Don't Miss

AllAfrica publishes around 800 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.